Zobrazeno 1 - 10
of 968
pro vyhledávání: '"James R. Cerhan"'
Autor:
Matthew E. Stokes, Kerstin Wenzl, C. Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew J. Maurer, Nicholas Stong, Yumi Nakayama, Lei Wu, Hsiling Chiu, Ann Polonskaia, Samuel A. Danziger, Fadi Towfic, Joel Parker, Rebecca L. King, Brian K. Link, Susan L. Slager, Vivekananda Sarangi, Yan W. Asmann, Joseph P. Novak, Akshay Sudhindra, Stephen M. Ansell, Thomas M. Habermann, Patrick R. Hagner, Grzegorz S. Nowakowski, James R. Cerhan, Anne J. Novak, Anita K. Gandhi
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract Immunochemotherapy has been the mainstay of treatment for newly diagnosed diffuse large B-cell lymphoma (ndDLBCL) yet is inadequate for many patients. In this work, we perform unsupervised clustering on transcriptomic features from a large c
Externí odkaz:
https://doaj.org/article/4dae5fe5634e4259b6d610f0ad207e8d
Autor:
Kerstin Wenzl, Matthew E. Stokes, Joseph P. Novak, Allison M. Bock, Sana Khan, Melissa A. Hopper, Jordan E. Krull, Abigail R. Dropik, Janek S. Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C. Chris Huang, Matthew J. Maurer, Lisa Rimsza, Brian K. Link, Susan L. Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Andrew L. Feldman, Rebecca L. King, Grzegorz Nowakowski, James R. Cerhan, Anita K. Gandhi, Anne J. Novak
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Recent genetic and molecular classification of DLBCL has advanced our knowledge of disease biology, yet were not designed to predict early events and guide anticipatory selection of novel therapies. To address this unmet need, we used an int
Externí odkaz:
https://doaj.org/article/01ad00fd8b6b4753b3568b00e0172eef
Autor:
Luca Arcaini, Côme Bommier, Juan Pablo Alderuccio, Michele Merli, Nicole Fabbri, Maria Elena Nizzoli, Matthew J. Maurer, Vittoria Tarantino, Simone Ferrero, Sara Rattotti, Annalisa Talami, Roberta Murru, Arushi Khurana, Raphael Mwangi, Marina Deodato, Emanuele Cencini, Francesca Re, Carlo Visco, Andrew L. Feldman, Brian K. Link, Marcia Torresan Delamain, Michele Spina, Ombretta Annibali, Alessandro Pulsoni, Andrés J.M. Ferreri, Caterina Cecilia Stelitano, Elsa Pennese, Thomas M. Habermann, Luigi Marcheselli, Sunwoo Han, Isildinha M. Reis, Marco Paulli, Izidore S. Lossos, James R. Cerhan, Stefano Luminari
Publikováno v:
EClinicalMedicine, Vol 72, Iss , Pp 102592- (2024)
Summary: Background: Marginal zone lymphomas (MZL), comprised of three unique but related subtypes, lack a unifying prognostic score applicable to all the patients in need for systemic chemotherapy and/or immunotherapy. Methods: Patients from the pro
Externí odkaz:
https://doaj.org/article/131b6a9da7b1426a967e61af7173f6d4
Autor:
Allison M. Bock, Jennifer J. Gile, Melissa C. Larson, Kittika Poonsombudlert, Reema K. Tawfiq, Seth Maliske, Matthew J. Maurer, Brian F. Kabat, Jonas Paludo, David J. Inwards, Sabarish Ayyappan, Brian K. Link, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, James R. Cerhan, Umar Farooq, Yucai Wang
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Over the last two decades, the frontline therapy for mantle cell lymphoma (MCL) has evolved. However, the impact of subsequent lines of therapy on survival outcomes has not been well characterized. In this study, we investigated the treatmen
Externí odkaz:
https://doaj.org/article/ab1b048610ec4f4e949d375e8ba8630b
Autor:
J. Erin Wiedmeier-Nutor, Chantal E. McCabe, Daniel R. O’Brien, Erik Jessen, Cecilia Bonolo de Campos, Nicholas J. Boddicker, Rosalie Griffin, Cristine Allmer, Kari G. Rabe, James R. Cerhan, Sameer A. Parikh, Neil E. Kay, Huihuang Yan, Daniel L. Van Dyke, Susan L. Slager, Esteban Braggio
Publikováno v:
Cancers, Vol 16, Iss 13, p 2450 (2024)
Chronic lymphocytic leukemia (CLL) is characterized by multiple copy number alterations (CNAs) and somatic mutations that are central to disease prognosis, risk stratification, and mechanisms of therapy resistance. Fluorescence in situ hybridization
Externí odkaz:
https://doaj.org/article/df67c463b81c49e2a220aa998415ea52
Autor:
Chung-il Wi, Madison J. Roy, Euijung Ryu, Philip H. Wheeler, Gokhan Anil, Kathy A. Madden, Folakemi T. Odedina, James R. Cerhan, Young J. Juhn
Publikováno v:
Journal of Clinical and Translational Science, Vol 8, Pp 30-30 (2024)
OBJECTIVES/GOALS: To tackle population-level health disparities, quality dashboards can leverage individual socioeconomic status (SES) measures, which are not always readily accessible. This study aimed to assess the feasibility of a population healt
Externí odkaz:
https://doaj.org/article/5e86b77efd894678b19949366052b809
Autor:
Cristina Correia, Matthew J. Maurer, Samantha J. McDonough, Paula A. Schneider, Paige E. Ross, Anne J. Novak, Andrew L. Feldman, James R. Cerhan, Susan L. Slager, Thomas E. Witzig, Bruce W. Eckloff, Hu Li, Grzegorz S. Nowakowski, Scott H. Kaufmann
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract How to identify follicular lymphoma (FL) patients with low disease burden but high risk for early progression is unclear. Building on a prior study demonstrating the early transformation of FLs with high variant allele frequency (VAF) BCL2 m
Externí odkaz:
https://doaj.org/article/2262c5bd3f494450bb8803bb96a17ff2
Autor:
Matthew J. Maurer, Carla Casulo, Melissa C. Larson, Thomas M. Habermann, Izidore S. Lossos, Yucai Wang, Loretta J. Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin, Jonathon B. Cohen, Brad S. Kahl, W Richard Burack, Jean L. Koff, Yong Mun, Anthony Masaquel, Mei Wu, Michael C. Wei, Ashwini Shewade, Jia Li, James R. Cerhan, Brian K. Link, Christopher R. Flowers
Publikováno v:
Haematologica, Vol 999, Iss 1 (2023)
Mosunetuzumab is a novel bispecific antibody targeting epitopes on CD3 on T cells and CD20 on B cells with the goal of inducing T-cell mediated elimination of malignant B cells. A recent pivotal phase I/II clinical trial (GO29781) demonstrated that m
Externí odkaz:
https://doaj.org/article/1d7e46afb331468e9c6f00cad9ff0929
Autor:
Celine M. Vachon, PhD, Aaron D. Norman, MPH, Kavita Prasad, MD, Dan Jensen, MPH, Gavin M. Schaeferle, BA, Kristy L. Vierling, MA, Meaghan Sherden, MPH, Michelle R. Majerus, MBA, FACHE, Katherine A. Bews, BA, Ethan P. Heinzen, MS, Amy Hebl, BS, Kathleen J. Yost, PhD, Richard B. Kennedy, PhD, Elitza S. Theel, PhD, Aditya Ghosh, MD, Meghan Fries, Chung-Il Wi, MD, Young J. Juhn, MD, Priya Sampathkumar, MD, William G. Morice, II, MD, PHD, Walter A. Rocca, MD, MPH, Aaron J. Tande, MD, James R. Cerhan, MD, PhD, Andrew H. Limper, MD, Henry H. Ting, MD, Gianrico Farrugia, MD, Rickey E. Carter, PhD, Lila J. Finney Rutten, PhD, Robert M. Jacobson, MD, Jennifer St. Sauver, PhD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 6, Pp 605-617 (2022)
Objective: To estimate rates and identify factors associated with asymptomatic COVID-19 in the population of Olmsted County during the prevaccination era. Patients and Methods: We screened first responders (n=191) and Olmsted County employees (n=564)
Externí odkaz:
https://doaj.org/article/21c1135734ae4447b5f6c7a5b431ab7e
Autor:
Paul Y. Takahashi, MD, MPH, Euijung Ryu, PhD, Gregory D. Jenkins, MS, Kathleen J. Yost, PhD, Christine R. Kirt, MPH, Nicole L. Larson, MPH, Ruchi Gupta, MS, James R. Cerhan, MD, PhD, Janet E. Olson, PhD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 6, Pp 552-563 (2022)
Objective: To determine the relationship between characteristics of employment and future hospitalization in older adults. Patients and Methods: We conducted a survey of adults aged 65 years or older participating in the Mayo Clinic Biobank. Using a
Externí odkaz:
https://doaj.org/article/b0d22292d8de44b5970f0f294d211f29